BTIG Reiterates Buy on Jade Biosciences, Maintains $39 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 90.8%

Neg 0% Neu 90.8% Pos 0%

BTIG analyst Julian Harrison reiterates Jade Biosciences (NASDAQ:JBIO) with a Buy and maintains $39 price target.

Comments

No comments yet. Be the first!